NYSEAM:BHB
NYSEAM:BHBBanks

Top Dividend Stocks Featuring First Interstate BancSystem And Two More

As the U.S. markets retreat from recent record highs, driven by a downturn in tech stocks and ongoing inflation concerns, investors are increasingly turning their attention to dividend stocks as a potential source of steady income. In this environment, selecting strong dividend-paying companies can be an attractive strategy for those seeking stability amid market volatility.
NYSE:PG
NYSE:PGHousehold Products

How P&G's Strong Q4 Earnings and Upbeat Outlook Could Impact Investors (PG)

On August 29, 2025, Procter & Gamble reported Q4 2025 earnings that exceeded analyst estimates, with adjusted EPS of US$1.48 and revenues of US$20.89 billion, and announced strong forward guidance for fiscal 2026. P&G’s announcement highlights management’s confidence in delivering ongoing organic sales and free cash flow growth, despite the challenging business backdrop. We'll examine how Procter & Gamble's robust earnings report and upbeat outlook could shape its investment narrative for...
NYSE:PAYC
NYSE:PAYCProfessional Services

A Closer Look at Paycom Software’s Valuation Following Executive Team Shift Toward Tech and Innovation

Kshitija Bhandaru
Paycom Software (PAYC) just made some major moves in its executive team, announcing new leadership roles focused on technology and automation. Shane Hadlock is taking on a dual role as both chief client officer and chief technology officer, while Rachael Gannon has been promoted to chief automation officer, effective August 18, 2025. The company also named Brad Smith as senior technical strategist. These changes indicate that Paycom is emphasizing both innovation and client experience,...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Did Landmark 10-Year Impella CP Data Just Shift Johnson & Johnson's (JNJ) Investment Narrative?

Johnson & Johnson recently announced that 10-year clinical trial results presented at the European Society of Cardiology Congress and published in the New England Journal of Medicine found that routine use of the Impella CP heart pump in patients with heart attacks complicated by cardiogenic shock led to a significant and increasing absolute reduction in mortality compared to standard care. The findings position Impella CP as the first mechanical circulatory support device proven in a...
NYSE:CVS
NYSE:CVSHealthcare

Did COVID-19 Vaccine Restrictions in 16 States Just Shift CVS Health's (CVS) Investment Narrative?

CVS Health recently announced it will not offer the 2025–2026 COVID-19 vaccine in 16 states and Washington, D.C., due to evolving regulatory requirements that limit vaccines to those endorsed by the Advisory Committee on Immunization Practices (ACIP). This restriction may significantly reduce vaccine access ahead of the upcoming respiratory virus season, raising operational and business challenges for pharmacy providers like CVS. We'll examine how CVS Health's decision to stop administering...
NYSE:PRU
NYSE:PRUInsurance

Prudential Financial (PRU): Rethinking Valuation After EssentialTerm Suite Expansion and New Capital Moves

Kshitija Bhandaru
Prudential Financial (PRU) has made some moves that could have investors pausing to reassess their outlook. The company rolled out enhancements to its EssentialTerm Suite, aiming to make term life insurance more flexible, easier to convert, and simpler to buy, especially for customers with meaningful coverage needs. In addition, Prudential has tapped capital markets with two new senior unsecured note offerings, adding fixed-income firepower to its balance sheet. These steps, focused on both...
NYSE:RERE
NYSE:RERESpecialty Retail

ATRenew (NYSE:RERE): Assessing Valuation After Profitable Quarter and Upbeat Guidance

Kshitija Bhandaru
There is a lot to digest after ATRenew (NYSE:RERE) released its second quarter results. The buzz is real as investors have watched this company swing from losses a year ago to strong profitability, and this latest report serves up more than just good news. ATRenew not only delivered higher earnings and revenue than expected, but also doubled down with an upbeat outlook for its next quarter. For anyone evaluating what to do next with the stock, these events stand to reshape the conversation...